DrugDashboards

Morphine Sulfate

Morphine Sulfate · MORPHINE SULFATE 40 mg/1 · Capsule, Extended Release · Oral · Amneal Pharmaceuticals of New York LLC

NDC 00115-1479-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$1,415.14
Reported to Texas DSHS · 2023 annual filing · Amneal Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for morphine sulfate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $28.78 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA200411
TE code
—
Approval date
Apr 12, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Morphine Sulfate (Capsule, Extended Release)

LabelerStrengthFirst seenLast seen
Actavis Pharma, Inc.MORPHINE SULFATE 90 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.MORPHINE SULFATE 120 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.MORPHINE SULFATE 30 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.MORPHINE SULFATE 45 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.MORPHINE SULFATE 60 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.MORPHINE SULFATE 75 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 80 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 50 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 30 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 60 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 20 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 100 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCMORPHINE SULFATE 40 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 20 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 30 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 80 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 50 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 60 mg/1Jul 15, 2026Sep 2, 2026
Nortec Development Associates, Inc.MORPHINE SULFATE 100 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 10 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 60 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 30 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 20 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 100 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 80 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCMORPHINE SULFATE 50 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Morphine Sulfate — NDC 00115-1479-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00115147901.

Free to cite with attribution — see how the data is put together.